Mitoxanthrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (19) , 3609-3614
- https://doi.org/10.1016/0006-2952(85)90744-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacology of mitoxantrone: mode of action and pharmacokineticsInvestigational New Drugs, 1985
- Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivoBiochemical Pharmacology, 1985
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983
- Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 systemClinical & Experimental Metastasis, 1983
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981
- Neutral proteinase inhibitors and antimetastatic effects in micePublished by Elsevier ,1980
- Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinonesJournal of Medicinal Chemistry, 1978
- Electron microscopic observations on formation of pulmonary metastasesJournal of Surgical Research, 1975
- The inhibition of the fatty acid oxygenase of sheep vesicular gland by antioxidantsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973